SUCCESSFUL MANAGEMENT OF PROPOFOL DEPENDENCE WITH PHENOBARBITAL IN AN ADULT PATIENT WITH COVID-19

ABSTRACT

B Discussion: b Extended courses of deep sedation are often required in mechanically ventilated COVID-19 patients and may result in withdrawal phenomena not previously seen with standard sedation practices. B Introduction: b Coronavirus Disease 2019 (COVID-19) brought unique challenges to the management of pain and agitation in mechanically ventilated patients. Over the next 36 hours, the patient received 5 more doses of phenobarbital 130 mg at 8 to 12 hour intervals until propofol was discontinued. [Extracted from the article] Copyright of Critical Care Medicine is the property of Lippincott Williams & Wilkins and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)